Affiliation:
1. Division of Drugs, National Institute of Health Sciences
Publisher
The Society of Powder Technology, Japan
Subject
Filtration and Separation,Fluid Flow and Transfer Processes,Process Chemistry and Technology,Catalysis
Reference7 articles.
1. [1] Act No. 47 of 2022, Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices (in Japanese).
2. [2] S. Naggie, D. R. Boulware, C. J. Lindsell, T. G. Stewart, N. Gentile, S. Collins, M. W. McCarthy, D. Jayaweera, M. Castro, M. Sulkowski, K. McTigue, F. Thicklin, G. M. Felker, A. A. Ginde, C. T. Bramante, A. J. Slandzicki, A. Gabriel, N. S. Shah, L. A. Lenert, S. E. Dunsmore, S. J. Adam, A. DeLong, G. Hanna, A. Remaly, R. Wilder, S. Wilson, E. Shenkman, A. F. Hernandez, Effect of ivermectin vs placebo on time to sustained recovery in outpatients with mild to moderate COVID-19: A randomized clinical trial, JAMA 328 (2022) 1595–1603.
3. [3] Ministry of Health, Labour and Welfare, Clinical Management of Patients with COVID-19, A guide for front-line healthcare workers Version 8.1. (in Japanese)
4. [4] P. Horby, W. S. Lim, J. R. Emberson, M. Mafham, J. L. Bell, L. Linsell, N. Staplin, C. Brightling, A. Ustianowski, E. Elmahi, B. Prudon, C. Green, T. Felton, D. Chadwick, K. Rege, C. Fegan, L. C. Chappell, S. N. Faust, T. Jaki, K. Jeffery, A. Montgomery, K. Rowan, E. Juszczak, J. K. Baillie, R. Haynes, M. J. Landray, Dexamethasone in hospitalized patients with COVID-19, N. Engl. J. Med. 384 (2021) 693–704.
5. [5] K. Maeda, Improvement of the value of antiviral drugs with the use of “Pharmacokinetic booster” (in Japanese), Drug Delivery System 35 (2020) 394–400.